Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1999-10-4
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0002-9297
pubmed:author
pubmed:issnType
Print
pubmed:volume
65
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
921-4
pubmed:dateRevised
2008-11-20
pubmed:meshHeading
pubmed-meshheading:10441598-Age Factors, pubmed-meshheading:10441598-Aged, pubmed-meshheading:10441598-Aged, 80 and over, pubmed-meshheading:10441598-BRCA2 Protein, pubmed-meshheading:10441598-Female, pubmed-meshheading:10441598-Founder Effect, pubmed-meshheading:10441598-Genes, BRCA1, pubmed-meshheading:10441598-Genes, Dominant, pubmed-meshheading:10441598-Genetic Predisposition to Disease, pubmed-meshheading:10441598-Germ-Line Mutation, pubmed-meshheading:10441598-Humans, pubmed-meshheading:10441598-Israel, pubmed-meshheading:10441598-Jews, pubmed-meshheading:10441598-Male, pubmed-meshheading:10441598-Middle Aged, pubmed-meshheading:10441598-Neoplasm Proteins, pubmed-meshheading:10441598-Prostate-Specific Antigen, pubmed-meshheading:10441598-Prostatic Neoplasms, pubmed-meshheading:10441598-Transcription Factors
pubmed:year
1999
pubmed:articleTitle
The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer.
pubmed:publicationType
Letter